On October 7, Twist Bioscience Corp fell 5.22% in regular trading, trading at $160.17/share with turnover of $42.8584 million.
Within the Biotechnology sector where Twist Bioscience Corp belongs, the overall sector performance was mixed. Among individual stocks, Apimeds Pharmaceutical U.S. Inc. rose 10.38%, Moderna rose 0.17%, Amgen rose 0.08%, Natera fell 0.81%, and Vaxcyte fell 1.12%.
Twist Bioscience Corporation engages in the manufacture and sale of synthetic DNA-based products, offering synthetic genes, oligo pools, NGS tools, and antibody optimization solutions for applications in therapeutics, diagnostics, agriculture, and data storage.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)